Ultima-Femara

ACTIVE HALF-LIFE 2 days
CLASSIFICATION Non-Steroidal Aromatase Inhibitor
DOSAGE 5 mg/day
ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Ultima Pharmaceuticals
LAB TEST See Document
WAREHOUSE International Warehouse 3
SUBSTANCE Letrozole

Introducing Ultima-Femara by Ultima Pharmaceuticals ? a powerful anti-estrogen medication that is making waves in both the medical and athletic arenas. Clinically, it is frequently prescribed for estrogen-dependent cancers, such as breast cancer in women. In the world of sports, it serves as a vital ally for men looking to counteract the unwanted effects of estrogenic steroids, including water retention and gynecomastia.

As a non-steroidal aromatase inhibitor, Ultima-Femara's active ingredient, Letrozole, distinguishes itself with a unique profile. This medication is recognized for its safety, as it is free from steroidal properties, androgenic activity, liver toxicity, and addictive risks.

Upon consumption, Ultima-Femara effectively blocks aromatase, the enzyme responsible for estrogen production. By inhibiting the cytochrome P450 enzyme within the aromatase system, it can lower estrogen levels by an impressive 75-95% with continued use.

Classified as a third-generation aromatase inhibitor, Ultima-Femara stands out among its peers, such as Anastrozole. Unlike Clomid and Nolvadex, which are estrogen receptor blockers that do not influence estrogen synthesis, Ultima-Femara tackles the root of estrogen production directly.

While generally regarded as safe when used as directed, Ultima-Femara may cause mild side effects in cases of misuse or overdose, potentially affecting various systems including the gastrointestinal (nausea, dry mouth), central nervous (dizziness, depression), respiratory (shortness of breath, coughing), and musculoskeletal (joint pain, osteoporosis). Should an overdose occur, symptomatic treatment is recommended.

Designed for oral use, Ultima-Femara is rapidly absorbed in the gastrointestinal tract with a remarkable 99% bioavailability, unaffected by food intake. The recommended dosage varies between 0.25 to 5 mg per day, tailored to individual tolerance and needs. Users can choose to take it either as a preventive measure against estrogen-related complications or as a treatment during a steroid cycle to manage symptoms as they arise. In both cases, it is a reliable solution for preventing side effects such as water retention, increased body fat, and gynecomastia in men.

Before commencing treatment with Ultima-Femara, it is crucial to evaluate any potential risks. Consultation with a healthcare provider is recommended to avoid contraindications, especially for women who are pregnant, breastfeeding, or have specific endocrine disorders, as well as those with known allergies to the medication's constituents.

Individuals with glucose-galactose malabsorption or lactase deficiency should exercise caution, although dosage modifications are typically unnecessary. Remember to keep this product out of reach of children and intended for adult use only.